Gingicaine Gel Strawberry
Product Images NDC 10129-036

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel Strawberry (NDC 10129-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Reach Out Of Reach Of Children (Children Page 001)

This text warns users to keep all Gingicaine Gel items away from young children and to consult a doctor immediately if a child ingests or swallows the product.*

FDA Label Image

Contraindications

This text provides important information about the contraindications of a certain product, such as not being used in patients with a history of hypersensitivity to certain types of local anesthetics and not being suitable for teething or infants and children under 2 years old.*

FDA Label Image

Gingicaine Strawberry Jar Label

This is a drug information sheet for an oral anesthetic containing 20% benzocaine. It can be used to provide pain relief for minor dental procedures, gum injuries, canker sores, sore throat, mouth/gum irritation caused by dentures or orthodontic appliances. However, it should not be used by people who are allergic to any “caine” local anesthetics or FD&C Red #40. The product is for external use only, and it should not be used in children under two years of age. It is important not to exceed the recommended dosage. The sheet also includes directions for use, precautions, contraindications, and dosage administration.*

FDA Label Image

Gingicaine In Syringe Box

GINGICaine® is a topical anesthesia gel that offers fast relief from pain or discomfort caused by minor dental procedures, gum injuries, cankor sores, sore throat, and other similar dental issues. It contains 20% benzocaine, a local anesthetic, in a flavored polyethylene glycol base. Gingicaine should not be applied to intact skin and should not be used in children under 2 years of age. Care should also be taken to avoid cross-contamination between patients. Do not exceed the recommended dosage. If symptoms such as cyanosis, headache, or shortness of breath develop, consult a doctor immediately. If swallowed accidentally, seek medical help or contact a poison control center immediately.*

FDA Label Image

Active Ingredients (Gingicaine Active Ingredients 001)

The product contains benzocaine 20% w/v as an active ingredient which works as an oral anesthetic.*

FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 001)

This is a warning label indicating that a product should not be used if the person has a history of allergy to any "caine" local anesthetics or FD&C Red #40.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

This text is a warning to avoid subjecting something to temperatures above 40°C or 104°F.*

FDA Label Image

Consult A Doctor (Gingicaine Consult A Doctor Gingicaine)

This text is a warning and cautionary advice about the usage of some product or medicine. It recommends consulting a doctor if symptoms persist or worsen after a certain period of time or if accompanied by other symptoms such as fever, headache, rash, nausea, and vomiting. The product should be kept out of reach of children, and accidental consumption more than the recommended dosage should be immediately reported to Poison Control or medical help sought. The product should also not come in contact with the eyes.*

FDA Label Image

Dosage And Admin001 (Gingicaine Dosage And Admin 001)

FDA Label Image

Dosage And Admin002 (Gingicaine Dosage And Admin 002)

This is a set of instructions for properly applying local anesthesia. It is recommended to use cotton rolls or saliva ejectors to avoid diluting the anesthetic. Sterile cotton or gauze must be used to avoid cross-contamination. The total dose should not exceed the required amount, and it should be applied to the affected area and left for at least one minute before being removed. It can be used up to four times per day, but it is important not to exceed the recommended dosage. This product is safe for adults and children 2 years of age and older, but younger children should consult a dentist or doctor.*

FDA Label Image

Indications (Gingicaine Indications 001)

This text describes the indications for using a particular product, which is intended to provide anesthesia to the mucous membranes of the oropharynx. It is designed to minimize pain associated with various procedures, including ulcers, needle punctures, scaling, and use of matrix bands. Additionally, the product can be used to help patients with a strong gag reflex during impressions or intraoral radiographs.*

FDA Label Image

Precaution (Gingicaine Precaution 001)

This text appears to be a set of precautions for dentists to follow when administering local anesthetics. They should avoid using them on infected or severely traumatized areas, as well as in areas of the throat that could prevent protective reflexes. Dentists should also be cautious when using the anesthetics on patients with known drug sensitivities or allergies to ester-type anesthetics. They should avoid contact with the anesthetics to prevent sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

This product is used to reduce pain or discomfort caused by minor dental procedures, minor gum injury, canker sores, sore throat, minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredients (Inactive Ingredient Page 001)

Polyethylene Glycol 3350 and Polyethylene Glycol 400 are chemical compounds used in a variety of applications such as pharmaceuticals, food additives, and personal care products. They are both a type of polyethylene glycol, a synthetic polymer that is soluble in water and has many useful properties. Polyethylene Glycol 3350 is often used as a laxative, while Polyethylene Glycol 400 is commonly used as a solvent or thickener in personal care products. Potassium Sodium Saccharate is a type of sweetener that is derived from sugar and is often used to reduce the sugar content in food and drinks.*

FDA Label Image

Purpose (Purpose Page 001)

Gingicaine Gel is a topical anesthetic used by Dentists just prior to an injection. Gingicaine is usually spread on a patients gum.*

FDA Label Image

Syringe Label

GINGICaine is a dental product made in the USA by GINGHPAK™. It is a topical anesthetic and is not meant for injection. The product should be destroyed after use, and there is a reference number and OT number provided on the packaging. The QR code and number 032026 are also included.*

FDA Label Image

Warnings

This is a warning message for a product cautioning against its use in children under 2 years of age. The product is for external use only, but its use may lead to a rare but severe condition known as methemoglobinemia, which reduces the amount of oxygen carried in blood. If any symptoms such as pale, gray, or blue skin color, headache, rapid heat rate, shortness of breath, dizziness or lightheadedness, fatigue, or lack of energy develop, stop using the product immediately and seek medical attention.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.